MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2025 Earnings Call Transcript August 14, 2025
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.06 EPS, expectations were $-0.55.
Operator: Good morning, and welcome to MiNK Therapeutics’ Second Quarter 2025 Conference Call and Webcast. [Operator Instructions] Please note that this event is being recorded. If anyone has any objections, you may disconnect at this time. I would now like to turn the conference over to Zack...
